Hosted on MSN4d
Parkinson's disease could be treated by FDA-approved cancer drug after major research breakthroughA major research breakthrough on Parkinson's disease revealed that an already FDA-approved cancer drug could help stem the ...
New research reveals a significant reduction in Parkinson’s disease risk among autoimmune patients treated with anti-TNF or ...
Inhibikase Therapeutics is pausing work on its experimental Parkinson’s disease drug risvodetinib and seeking “strategic ...
In a large cohort of patients with autoimmune diseases, treatment with biologic disease-modifying antirheumatic drugs was ...
Researchers from the Cleveland Clinic Genome Center have successfully applied advanced artificial intelligence (AI) genetics ...
The findings revealed a potential link between the use of these drugs and an increased risk of Parkinson’s disease. The risk ...
The FDA approved a monthly maintenance dosing of intravenous lecanemab (Leqembi) for early Alzheimer's disease, said ...
Advanced artificial intelligence genetics models have been successfully applied to Parkinson’s disease at CCGC.
Continuous dopaminergic stimulation is a therapeutic strategy for the management of Parkinson's disease ... of levodopa that provides comparable anti-parkinsonian benefits without motor complications.
In light of that efficacy and best-in-class drug candidate, the contrast between the U.S. market size for Parkinson’s disease of $4.3 billion – another report has estimated a $6.3 billion ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback